Literature DB >> 29622075

Staging Lung Cancer: Regional Lymph Node Classification.

Ahmed H El-Sherief1, Charles T Lau2, Brett W Carter3, Carol C Wu3.   

Abstract

This article reviews regional lymph node assessment in lung cancer. In the absence of a distant metastasis, the absence or location of lung cancer spread to a regional mediastinal lymph node affects treatment options and prognosis. Regional lymph node maps have been created to standardize assessment of the N descriptor. The International Association for the Study of Lung Cancer lymph node map is used for the standardization of N descriptor assessment. CT, PET/CT with fluorodeoxyglucose, endobronchial ultrasound-guided and/or esophageal ultrasound-guided biopsy, and mediastinoscopy are common modalities used to determine the N descriptor. Published by Elsevier Inc.

Entities:  

Keywords:  International association for the study of lung cancer (IASLC); Lung cancer; Lymph node; Lymph node map; Staging

Mesh:

Year:  2018        PMID: 29622075     DOI: 10.1016/j.rcl.2018.01.008

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

Review 1.  Correlation between the Expression of VEGF and Ki67 and Lymph Node Metastasis in Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Dong Wei; Yunchao Xin; Yu Rong; Yanbing Hao
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-28       Impact factor: 2.650

2.  Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma ≤ 3 cm in diameter.

Authors:  Cheng Chang; Maomei Ruan; Bei Lei; Jian Feng; Wenhui Xie; Hong Yu; Wenlu Zhao; Yaqiong Ge; Shaofeng Duan; Wenjing Teng; Qianfu Wu; Xiaohua Qian; Lihua Wang; Hui Yan; Ciyi Liu; Liu Liu
Journal:  EJNMMI Res       Date:  2022-04-21       Impact factor: 3.434

3.  Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.

Authors:  Tingting Qin; Zhujun Liu; Jing Wang; Junling Xia; Shaochuan Liu; Yanan Jia; Hailin Liu; Kai Li
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

4.  The Prognostic Significance of Preoperative Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Operated for Non-Small Cell Lung Cancer.

Authors:  Mariusz Łochowski; Justyna Chałubińska-Fendler; Izabela Zawadzka; Barbara Łochowska; Marek Rębowski; Daniel Brzeziński; Józef Kozak
Journal:  Cancer Manag Res       Date:  2021-10-09       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.